PulmoBioMed has developed a non-invasive mouthpiece to collect fluid samples from the lungs to detect conditions like asthma.
PulmoBioMed has raised €1.6M across 1 funding round from 3 investors, most recently a round in Feb 2024. Based in Newcastle upon Tyne, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-02-08 | Other | €1.6M |
| North East Venture Fund,Private Investors,SFC Capital |
| View deal → |
